Faraday Pharmaceuticals, Inc.
Clinical trials sponsored by Faraday Pharmaceuticals, Inc., explained in plain language.
-
New drug aims to protect hearts after attack
Disease control CompletedThis study tested a new medicine called FDY-5301 in 120 people having a severe heart attack (STEMI). Participants received either the drug or a placebo during a procedure to open blocked arteries. The main goal was to see if the drug could reduce dangerous heart rhythm problems a…
Phase: PHASE2 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New shot aims to save hearts after major attack
Disease control CompletedThis study tested a single injection of FDY 5301 in over 2,300 people who had a severe type of heart attack (anterior STEMI) and were getting emergency artery-opening treatment. The goal was to see if the drug could lower the chance of dying or developing heart failure within a f…
Phase: PHASE3 • Sponsor: Faraday Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:44 UTC